Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Karyopharm Therapeut

(NASDAQ: KPTI)
Add to Portfolio
-0.18 (-1.52%)
as of Sep 17, 2019

Profile
Ticker Symbol KPTI
Exchange NASDAQ
Contact Information
85 WELLS AVENUE SECOND FLOOR
NEWTON, MA USA
P: 617-658-0600
CEO/President Michael G. Kauffman
Earnings at a Glance
Earnings 06/30/19
-0.71
03/31/19
-1.09
12/31/18
-0.97
09/30/18
-0.79
Price Earnings Ratio N/A
EPS Growth -15.83
Most Recent Earnings ($) -0.71
Annual EPS ($) -3.55
Business Summary
Karyopharm Therapeutics Inc. is a clinical-stage pharmaceutical company focused on the discovery and development of drugs for the treatment of cancer and other major diseases. It serves the healthcare industry throughout the United States. Karyopharm Therapeutics Inc. is based in United States.
Industry/Sector SIC-2834 Pharmaceutical Preparations
Medical - Drugs
Indices Nasdaq Composite
Indices Russell 3000
Indices Russell 2000